Amarin Corp PLC (AMRN)
0.8845
+0.05
(+6.57%)
USD |
NASDAQ |
May 02, 13:15
Amarin Cash from Investing (Quarterly): -71.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -71.00M |
| September 30, 2023 | 30.77M |
| June 30, 2023 | 34.32M |
| March 31, 2023 | -19.61M |
| December 31, 2022 | -27.82M |
| September 30, 2022 | 30.87M |
| June 30, 2022 | 73.19M |
| March 31, 2022 | 99.05M |
| December 31, 2021 | 25.02M |
| September 30, 2021 | -99.49M |
| June 30, 2021 | 50.65M |
| March 31, 2021 | 127.93M |
| December 31, 2020 | 23.69M |
| September 30, 2020 | -4.359M |
| June 30, 2020 | -102.47M |
| March 31, 2020 | -293.82M |
| December 31, 2019 | -0.364M |
| September 30, 2019 | -1.313M |
| June 30, 2019 | -0.801M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.005M |
| September 30, 2018 | -0.053M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.012M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.021M |
| December 31, 2015 | -0.018M |
| September 30, 2015 | -0.01M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.014M |
| December 31, 2012 | -12.63M |
| September 30, 2012 | -0.626M |
| June 30, 2012 | -0.997M |
| March 31, 2012 | -0.092M |
| December 31, 2011 | -0.365M |
| September 30, 2011 | -1.674M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-293.82M
Minimum
Mar 2020
127.93M
Maximum
Mar 2021
-6.609M
Average
-0.364M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Trinity Biotech PLC | -0.891M |
| DBV Technologies SA | -0.187M |
| Adaptimmune Therapeutics PLC | 68.20M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.645M |
| Cash from Financing (Quarterly) | 0.083M |
| Free Cash Flow | 6.347M |
| Free Cash Flow Per Share (Quarterly) | -0.0028 |
| Free Cash Flow to Equity (Quarterly) | -1.154M |
| Free Cash Flow to Firm (Quarterly) | -1.154M |
| Free Cash Flow Yield | 1.76% |